European evidence based consensus on the diagnosis and management of Crohn’s disease: current management

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Gut

• Publication date

  2006-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/gut.2005.081950bPMID 16481629PMCID PMC1859997
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse.

  2009cited by this paper
• Budesonide for induction of remission in Crohn's disease.

  2008cited by this paper
• [Laparoscopic ileocecal resection for Crohn's disease].

  2007cited by this paper
• Fontolizumab, a humanised anti-interferon γ antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn’s disease

  2006cited by this paper
• A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine.

  2005cited by this paper
• A randomized, double‐blind, placebo‐controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor‐α, in patients with corticosteroid‐dependent Crohn's disease

  2005cited by this paper
• The promise and perils of interpreting genetic associations in Crohn’s disease

  2005cited by this paper
• Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease.

  2005cited by this paper
• Budesonide for Maintenance of Remission in Patients with Crohn's Disease in Medically Induced Remission: A Predetermined Pooled Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials

  2005cited by this paper
• Natalizumab induction and maintenance therapy for Crohn's disease.

  2005cited by this paper
• A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.

  2005cited by this paper
• Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.

  2005cited by this paper
• Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

  2005cited by this paper
• Should adults be screened for celiac disease? What are the benefits and harms of screening?

  2005cited by this paper
• Controlled trial of antimycobacterial therapy in Crohn's disease

  2005cited by this paper
• A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator.

  2005cited by this paper
• Interleukin-10 producing Lactococcus lactis for the treatment of Crohn??s disease

  2005cited by this paper
• Management of Recent Onset Crohn’s Disease: A Controlled, Randomized Trial Comparing Step-up and Top-down Therapy

  2005cited by this paper
• Diagnosing Helicobacter pylori in vivo by confocal laser endoscopy.

  2005cited by this paper
• Budesonide for induction of remission in Crohn's disease.

  2005cited by this paper
• Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease

  2005cited by this paper
• Limiting fracture risk in Crohn's disease: is there anything better than calcium and vitamin D?

  2005cited by this paper
• Methotrexate for induction of remission in refractory Crohn's disease.

  2005cited by this paper
• Resetting the immune system in refractory Crohn's disease: is autologous hematopoietic stem cell transplantation the way forward?

  2005cited by this paper
• Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease.

  2005cited by this paper
• Advances in therapeutic approaches to ulcerative colitis and crohn’s disease

  2005cited by this paper
• Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo.

  2004cited by this paper
• Newer markers for hepatocellular carcinoma.

  2004cited by this paper
• How effective are the usual treatments for Crohn's disease?

  2004cited by this paper
• Microscopic colitis: a missed diagnosis?

  2004cited by this paper
• Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County

  2004cited by this paper
• 5-ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion.

  2004cited by this paper
• Anti-interleukin-12 antibody for active Crohn's disease.

  2004cited by this paper
• Early Hepatic Nodular Hyperplasia and Submicroscopic Fibrosis Associated With 6-Thioguanine Therapy in Inflammatory Bowel Disease

  2004cited by this paper
• Long strictureplasty is as safe and effective as short strictureplasty in small‐bowel Crohn's disease

  2004cited by this paper
• Optimizing anti-TNF treatment in inflammatory bowel disease.

  2004cited by this paper
• Anastomotic configuration does not affect recurrence of Crohn's disease after ileocolonic resection

  2004cited by this paper
• An Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Prior Loss of Response or Intolerance to Infliximab for Crohn's Disease

  2004cited by this paper
• CDP571, a humanised monoclonal antibody to tumour necrosis factor α, for moderate to severe Crohn’s disease: a randomised, double blind, placebo controlled trial

  2004cited by this paper
• Crohn's disease over 20 years after diagnosis in a referral population.

  2004cited by this paper
• CDP 571 , a humanised monoclonal antibody to tumour necrosis factor a , for moderate to severe Crohn ’ s disease : a randomised , double blind , placebo controlled trial

  2004cited by this paper
• Side-to-side isoperistaltic strictureplasty in the treatment of extensive Crohn's disease.

  2004cited by this paper
• 5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study.

  2004cited by this paper
• Nodular regenerative hyperplasia in IBD patients on 6-thioguanine: A multicenter safety assessment by MRI and liver biopsy

  2004cited by this paper
• Indications and results of side-to-side isoperistaltic strictureplasty in Crohn’s disease

  2004cited by this paper
• A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease.

  2004cited by this paper
• Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.

  2004cited by this paper
• Systematic review: how effective are the usual treatments for Crohn's disease?

  2004cited by this paper
• The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients.

  2004cited by this paper
• Elemental diet modulates the growth of Clostridium difficile in the gut flora

  2004cited by this paper
• Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials.

  2004cited by this paper
• Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis.

  2004cited by this paper
• Early Postoperative Complications are not Increased in Patients with Crohn's Disease Treated Perioperatively with Infliximab or Immunosuppressive Therapy

  2004cited by this paper
• The clinical characteristics and outcome of intraabdominal abscess in Crohn’s disease

  2004cited by this paper
• The risk of post‐operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study

  2004cited by this paper
• Short‐term adverse effects of 5‐aminosalicylic acid agents in the treatment of ulcerative colitis

  2004cited by this paper
• Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Örebro, Sweden, 1993–1998

  2004cited by this paper
• Role of stapled and hand-sewn anastomoses in recurrence of Crohn's disease.

  2004cited by this paper
• A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease.

  2004cited by this paper
• A Randomized Double-blind Placebo-controlled Trial

  2004cited by this paper
• Multivariate analysis suggests improved perioperative outcome in Crohn's disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty.

  2003cited by this paper
• Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine

  2003cited by this paper
• Laparoscopic ileocecal resection in Crohn's disease: a case-matched comparison with open resection.

  2003cited by this paper
• CD 28-dependent Rac 1 activation is the molecular target of azathioprine in primary human CD 4 + T lymphocytes

  2003cited by this paper
• Crohn's disease: step up or top down therapy.

  2003cited by this paper
• A New Model of Strictureplasty for Multiple and Long Stenoses in Crohn’s Ileitis

  2003cited by this paper
• Corticosteroids for maintenance of remission in Crohn's disease.

  2003cited by this paper
• Budesonide versus predinisolone in the management of Crohn's disease: A randomized multi-national 2-year study

  2003cited by this paper
• Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.

  2003cited by this paper
• Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.

  2003cited by this paper
• Bioavailability of oral vs. subcutaneous low‐dose methotrexate in patients with Crohn's disease

  2003cited by this paper
• Thiopurine therapy: when to start and when to stop

  2003cited by this paper
• Osteoporosis in inflammatory bowel disease

  2003cited by this paper
• The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study.

  2003cited by this paper
• Rational Dosing of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Diseases

  2003cited by this paper
• Hepatotoxicity associated with 6-thioguanine therapy for Crohn's disease.

  2003cited by this paper
• [Strictureplasty in the surgical treatment of complicated Crohn's disease].

  2003cited by this paper
• Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients.

  2003cited by this paper
• Gastroduodenal Crohn's disease: medical management.

  2003cited by this paper
• 6-thioguanine can cause serious liver injury in inflammatory bowel disease patients.

  2003cited by this paper
• Long-Term Results of Ileal Pouch–Anal Anastomosis in Crohn's Disease

  2003cited by this paper
• Remission maintenance by tioguanine in chronic active Crohn's disease

  2003cited by this paper
• Methotrexate for induction of remission in refractory Crohn's disease.

  2003cited by this paper
• Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial.

  2003cited by this paper
• [Colorectal Crohn's disease: indications to surgical treatment].

  2003cited by this paper
• Colonoscopic balloon dilation of Crohn's strictures: a review of long‐term outcomes

  2003cited by this paper
• Does stapled functional end-to-end anastomosis affect recurrence of Crohn's disease after ileocolonic resection?

  2003cited by this paper
• Long-term outcome of endoscopic pneumatic dilatation in Crohn's disease.

  2003cited by this paper
• Methotrexate: first-line or second-line immunomodulator?

  2003cited by this paper
• Endoscopic hydrostatic dilatation of intestinal strictures in Crohn' s disease.

  2003cited by this paper
• CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes.

  2003cited by this paper
• Risk Factors for Ileoanal J Pouch-Related Septic Complications in Ulcerative Colitis and Familial Adenomatous Polyposis

  2002cited by this paper
• Percutaneous abscess drainage in Crohn disease: technical success and short- and long-term outcomes during 14 years.

  2002cited by this paper
• Azathioprine or 6-Mercaptopurine Before Colectomy for Ulcerative Colitis Is Not Associated With Increased Postoperative Complications

  2002cited by this paper
• The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review

  2002cited by this paper
• The efficacy of methotrexate for maintaining remission in inflammatory bowel disease

  2002cited by this paper
• Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial.

  2002cited by this paper
• Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark.

  2002cited by this paper
• Segmental Resection or Subtotal Colectomy in Crohn’s Colitis?

  2002cited by this paper
• Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy

  2002cited by this paper

• Micro-fragmented adipose tissue—An innovative therapeutic approach: A narrative review

  2025cites this paper
• ACG Clinical Guideline: Management of Crohn's Disease in Adults

  2025cites this paper
• Durable clinical and deep remission with ustekinumab in perianal fistulizing Crohn's disease: A 2-year retrospective real-world cohort study.

  2025cites this paper
• The prevalence of and risk factors for bronchiectasis in inflammatory bowel disease: a chest CT-based case-control study.

  2025cites this paper
• Clinical features and short-term disease progression of asymptomatic perianal fistulizing Crohn's disease.

  2025cites this paper
• ASPECTS EPIDEMIO-CLINIQUES ET THERAPEUTIQUES DES STENOSES INTESTINALES CROHNIENNES SYMPTOMATIQUES

  2025cites this paper
• Ileocaecal Crohn's disease. To resect or not to resect, is that the question?

  2024cites this paper
• Global, regional, and national burden of inflammatory bowel disease, 1990–2021: Insights from the global burden of disease 2021

  2024cites this paper
• National diagnostic and care protocols (NDCP) for hematopoietic stem cell transplantation in autoimmune diseases.

  2024cites this paper
• Depletion of core microbiome forms the shared background against diverging dysbiosis patterns in Crohn’s disease and intestinal tuberculosis: insights from an integrated multi-cohort analysis

  2024cites this paper
• The Natural History of Crohn's Disease Leading to Intestinal Failure: A Longitudinal Cohort Study from 1973 to 2018.

  2024cites this paper
• The effectiveness of two-stage surgical treatment of children with complicated Crohn’s disease

  2023cites this paper
• Successful treatment of a refractory intestinal Behcet’s disease with an oncology history by Vedolizumab: a case report and literature review

  2023cites this paper
• Combining pharmacometric models with predictive and prognostic biomarkers for precision therapy in Crohn's disease: A case study of brazikumab

  2023cites this paper
• Dietary polyphenols ameliorate inflammatory bowel diseases: advances and future perspectives to maximize their nutraceutical applications

  2023cites this paper
• CURRENT STATUS, PROBLEMS AND PROSPECTS OF ULCERATIVE COLITIS MEDICAL CORRECTION (LITERATURE REVIEW)

  2023cites this paper
• The synergistic effect of epigallocatechin-3-gallate and quercetin co-loaded hydrogel beads on inflammatory bowel disease.

  2023cites this paper
• Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey

  2022cites this paper
• Postoperative Complications Are Associated With an Early and Increased Rate of Disease Recurrence After Surgery for Crohn’s Disease

  2022cites this paper
• Core indicators of an evaluation and guidance system for quality of care in inflammatory bowel disease centers: A critical review

  2022cites this paper
• Comparison of Diagnostic Performance of Ultrasonography and Magnetic Resonance Enterography in the Assessment of Active Bowel Lesions in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis

  2022cites this paper
• A COMPARATIVE STUDY BETWEEN TGI (TOTAL GUT IRRIGATION) GUIDED V/S NON TGI GUIDED MANAGEMENT OF ACUTE FECAL FISTULA.

  2022cites this paper
• Prognostic Factors of Biologic Therapy in Pediatric IBD

  2022cites this paper
• Probing predilection to Crohn's disease and Crohn's disease flares: A crowd-sourced bioinformatics approach

  2022cites this paper
• Current and future aspects of IBD research and treatment: The 2022 perspective

  2022cites this paper
• Polyphenols from food by-products: An alternative or complementary therapy to IBD conventional treatments.

  2021cites this paper
• Poor Concordance Between Clinical Activity and Endoscopic Severity in Pediatric Crohn’s Disease: Before and After Induction Therapy

  2021cites this paper
• Symptomatic Improvement and Mucosal Healing in UC Patients – A ShortTerm Randomised Trial Comparing Tofacitinib with Mesalamine

  2021cites this paper
• Phenotype of Crohn’s disease according to the Montreal classification in relation to dental health status

  2021cites this paper
• Difficulties in the differential diagnosis of intestinal tuberculosis and Crohn‘s disease

  2021cites this paper
• Description of the inflammatory bowel disease natural history in Tehran province, Iran: Mixed panel approaches

  2021cites this paper
• Inflammation and fibrosis in Crohn’s disease: location-matched histological correlation of small bowel ultrasound features

  2020cites this paper
• Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients?

  2020cites this paper
• Ultrasound findings of Crohn’s disease: correlation with MR enterography

  2020cites this paper
• Anti-tubercular therapy given to differentiate Crohn's disease from intestinal tuberculosis predisposes to stricture formation.

  2020cites this paper
• Pemphigus Vulgaris: A Retrospective Cohort Study of Clinical Features, Treatments, and Outcomes

  2020cites this paper
• Descripción epidemiológica y tratamiento de los pacientes con Enfermedad de Crohn

  2020cites this paper
• Influence of Pharmaceutical Direct-to-Consumer Advertisement on Medical Treatment of Inflammatory Bowel Disease—An Outpatient Survey-Based Study

  2020cites this paper
• Serum Serotonin Differentiates Between Disease Activity States in Crohn’s Patients

  2020cites this paper
• Pemphigus Vulgaris: A Retrospective Cohort Study of Clinical Features, Treatments, and Outcomes.

  2020influential citation
• The New Proactive Approach and Precision Medicine in Crohn’s Disease

  2020cites this paper
• Diet Advice for Crohn’s Disease: FODMAP and Beyond

  2020cites this paper
• Integrated serum proteins and fatty acids analysis for putative biomarker discovery in inflammatory bowel disease.

  2019cites this paper
• Ingestible Contrast Agents for Gastrointestinal Imaging

  2019cites this paper
• Application value of tissue tuberculosis antigen combined with Xpert MTB/RIF detection in differential diagnoses of intestinal tuberculosis and Crohn’s disease

  2019cites this paper
• Effect of Oral Nutrition Supplements and TGF-β2 on Nutrition and Inflammatory Patterns in Patients With Active Crohn's Disease.

  2019cites this paper
• Inducing remission in paediatric Crohn's disease using nutritional therapies - A systematic review.

  2019cites this paper
• Nutritional Rehabilitation in Patients with Malnutrition Due to Crohn’s Disease

  2019cites this paper
• Risk factors for recurrence after bowel resection for Crohn’s disease

  2019cites this paper
• No increased risk of nephrotoxicity associated with 5‐aminosalicylic acid in IBD: a population‐based cohort and nested case‐control study

  2019cites this paper
• Preclinical evaluation of EPHX2 inhibition as a novel treatment for inflammatory bowel disease

  2019cites this paper
• Cross-Sectional Imaging in Crohn’s Disease

  2019cites this paper
• A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease

  2019cites this paper
• Pharmacokinetics-Based Dosing Strategies for Therapeutic Proteins in Inflammatory Bowel Disease

  2019cites this paper
• FARMÁCIA CLÍNICA E DOENÇA DE CROHN COMPLICADA: RELATO DE CASO

  2019cites this paper
• Crohn Disease and Its Surgical Management

  2019cites this paper
• Thiopurine Methyltransferase genetic polymorphisms and activity and metabolic products of azathioprine in patients with inflammatory bowel disease.

  2019cites this paper
• Functional Cross-Sectional Imaging Techniques in Crohn’s Disease

  2019cites this paper
• Exploration of personality in the patients with the inflammatory bowel disease

  2019cites this paper
• Effects of Azithromycin on Behavior, Pathologic Signs, and Changes in Cytokines, Chemokines, and Neutrophil Migration in C57BL/6 Mice Exposed to Dextran Sulfate Sodium.

  2019cites this paper
• Online Health Resource Use by Individuals With Inflammatory Bowel Disease: Analysis Using the National Health Interview Survey

  2019cites this paper
• Crohn's disease.

  2019cites this paper
• Pharmacotherapy of inflammatory boweldisease

  2018cites this paper
• Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease

  2018cites this paper
• Different Genetic Expression Profiles of Oxidative Stress and Apoptosis-Related Genes in Crohn’s Disease

  2018cites this paper
• University of Birmingham Pharmacokinetics and exposure response relationships of ustekinumab in patients with Crohn's Disease

  2018cites this paper
• A risk score system to timely manage treatment in Crohn’s disease: a cohort study

  2018cites this paper
• Is top-down therapy a more effective alternative to conventional step-up therapy for Crohn’s disease?

  2018cites this paper
• Comparison of Conventional Ultrasound and Contrast Enhanced Magnetic Resonance (MR) Enterography in Evaluation Patients with Crohn’s Disease

  2018cites this paper
• Allergic and Immunologic Perspectives of Inflammatory Bowel Disease

  2018cites this paper
• Improvement of psychological status after infliximab treatment in patients with newly diagnosed Crohn’s disease

  2018influential citation
• The assessment of online health videos for surgery in Crohn's disease

  2018cites this paper
• Dashboards for Therapeutic Monoclonal Antibodies: Learning and Confirming

  2018cites this paper
• Conventional and biological therapy for inflammatory bowel disease.

  2018cites this paper
• Small Bowel Capsule Endoscopy in Crohn ’ s Disease and Controls : Upper Lesions , Impact and Transit Times in a Tertiary Referral

  2018influential citation
• Developing and piloting an intervention for the management of inflammatory bowel disease-fatigue

  2018cites this paper
• MRI for Crohn's disease : From quantification to automation

  2018cites this paper
• HLA-DQ: Celiac disease vs inflammatory bowel disease

  2018cites this paper
• ACG Clinical Guideline: Management of Crohn’s Disease in Adults

  2018cites this paper
• Differentiation of Crohn’s disease from intestinal Tuberculosis and Ulcerative Colitis: a single tertiary centre experience in Nepal

  2018cites this paper
• Crohn’s Disease Treatment Expenditures over Fifteen Years of Follow-Up

  2018cites this paper
• Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.

  2018cites this paper
• B1a Lymphocytes (CD19+CD5+) Deficiency in Patients with Crohn’s Disease and Its Relation with Disease Severity

  2018cites this paper
• Guideline recommendations for treatment of patients with inflammatory bowel diseases are not implemented in clinical practice—results of a non-representative survey

  2018cites this paper
• Long-term Outcome of Early Combined Immunosuppression Versus Conventional Management in Newly Diagnosed Crohn’s Disease

  2018cites this paper
• Efficacy of herb-partitioned moxibustion at Qihai (CV 6) and bilateral Tianshu (ST 25) on colonic damage and the TLR4/NF-κB signaling pathway in rats with Crohn's disease

  2018cites this paper
• Current Progress of Endoscopy in Inflammatory Bowel Disease: MR Enterography

  2018cites this paper
• CD4+ CD25+ FOXP3+ T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn’s disease

  2018cites this paper
• Development of a Novel Predictive Model for the Clinical Course of Crohn's Disease: Results from the CONNECT Study

  2017cites this paper
• [Second Korean Guidelines for the Management of Crohn's Disease].

  2017cites this paper
• Comparative Study of Two Cohorts of Newly Diagnosed Crohn's Disease Demonstrates Change in Therapeutic Strategies

  2017cites this paper
• Endoscopic and clinical responses to anti‐tubercular therapy can differentiate intestinal tuberculosis from Crohn's disease

  2017cites this paper
• Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells – Effects on gene expression levels and thiopurine metabolism

  2017cites this paper
• Bowel perforation in Crohn's Disease: correlation between CDAI and Clavien-Dindo scores.

  2017cites this paper
• Diffusion-weighted Magnetic Resonance Imaging in Crohn Disease: Current Status and Recommendations

  2017cites this paper
• 5-Aminosalicylates to maintain remission in Crohn’s disease: Interpreting conflicting systematic review evidence

  2017cites this paper
• Establishing Key Performance Indicators [KPIs] and Their Importance for the Surgical Management of Inflammatory Bowel Disease–Results From a Pan-European, Delphi Consensus Study

  2017cites this paper
• Perspectives on Enterocutaneous Fistula: A Review Article

  2017cites this paper
• Capsule endoscopy in small bowel Crohn’s disease and Tuberculosis

  2017cites this paper
• Recent Advances in the Medical Treatment of Crohn's Disease

  2017cites this paper